This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
